Infectious Complications, Associated Factors, and Prognosis After Esophagectomy for Cancer: A French, Multicenter, Retrospective Study

What this Trial Is About

This research aims to understand infectious complications after esophagectomy for cancer, focusing on patients admitted to intensive care following surgery between 2017 and 2024. These complications, such as pneumonia, are common postoperative issues that increase risks and hospital stays, significantly affecting patient quality of life. The study seeks to identify factors linked to these infections to help improve outcomes for patients undergoing this complex surgery. The study collects retrospective, pseudonymized data from multiple centers, reviewing medical records of patients who had esophagectomy for cancer and were admitted to intensive care. Data includes infection incidence, types of pathogens, resistance patterns, and antibiotic treatments used. Patient information is carefully coded and securely stored at each center, with data collection proceeding only if patients do not oppose use of their information. Participants will not be actively involved in the study process since it uses past medical records. Researchers will analyze the frequency and nature of infections within 28 days after surgery, assess related complications like sepsis or organ failure, and examine factors associated with infection occurrence. The study is observational and will monitor outcomes retrospectively to better understand infection risks and their impact on hospital stay lengths and patient prognosis.

Infectious Complications After Esophagectomy